Imatinib Mesylate 100mg

What Is Imatinib Mesylate 100mg –

Imatinib Mesylate 100mg tablet is a targeted anti-cancer medicine. It is used to treat certain types of blood cancer and tumors. It is mainly prescribed for chronic myeloid leukemia (CML). It is also used for some cases of gastrointestinal stromal tumors (GIST).

This medicine is part of targeted therapy. It works by acting on specific cancer cells. It does not affect all cells in the body like traditional chemotherapy.

A qualified specialist such as an oncologist or hematologist prescribes this medicine. The doctor decides the dose after proper diagnosis. It is a prescription-only cancer medicine.

Patients should not take this medicine without medical supervision. Doctors include it in long-term cancer treatment plans. Regular monitoring is required during therapy.

Uses of Imatinib Mesylate 100mg / Imatinib Used For

Imatinib Mesylate 100mg tablet is used to treat serious diseases related to abnormal cell growth.

It is mainly prescribed for chronic myeloid leukemia (CML). This is a blood cancer where bone marrow produces too many abnormal white blood cells.

It is also used for some cases of acute lymphoblastic leukemia (ALL). Doctors prescribe it only when specific gene changes are present.

This medicine is also used for gastrointestinal stromal tumors (GIST). These are rare tumors in the stomach or digestive tract.

In some cases, doctors may use it for other tyrosine kinase-related cancers or disorders.

Overall, Imatinib Mesylate 100mg helps control cancer growth. It also helps slow disease progression and improves treatment outcomes.

How Imatinib Mesylate 100mg Works –

Imatinib Mesylate 100mg works by blocking abnormal proteins in cancer cells. These proteins are called tyrosine kinases.

These proteins send signals that make cancer cells grow. This medicine stops those signals.

In CML, a faulty protein called BCR-ABL is present. This medicine blocks that protein.

When the protein is blocked:

cancer cell growth slows down

abnormal cells stop multiplying

blood cell balance improves

disease progression reduces

This medicine works in a targeted way. It mainly affects cancer cells. It protects most healthy cells compared to traditional chemotherapy.

Because of this, Imatinib Mesylate 100mg tablet is called a targeted cancer therapy (TKI).

Side Effects of Imatinib Mesylate 100mg

Imatinib Mesylate 100mg may cause side effects. These effects vary from person to person.

Common side effects include nausea, vomiting, diarrhea, fatigue, and muscle cramps. These are usually mild.

Some patients may feel tired or weak during treatment.

Fluid retention may occur in some cases. This can cause swelling in the face, ankles, or eyes.

Other possible effects include skin rash, headache, and stomach discomfort.

Less common but serious side effects include:

low blood cell counts

liver problems

severe swelling or breathing difficulty

Doctors monitor these effects through regular blood tests and liver function tests.

Patients should contact a doctor if side effects become severe.

Safety & Precautions

Imatinib Mesylate 100mg should only be taken under the supervision of a qualified oncologist or hematologist. It is a strong targeted cancer medicine.

Take the medicine exactly as prescribed. Do not change the dose. Do not stop treatment without medical advice.

Doctors recommend regular blood tests and liver function monitoring. These tests help track safety and treatment progress.

Avoid alcohol during treatment. Alcohol can increase liver stress and side effects.

Tell your doctor about all other medicines you are using. This helps prevent drug interactions.

Pregnant and breastfeeding women should use this medicine only if a doctor clearly advises it. Effective contraception may be required during treatment.

Always buy Imatinib Mesylate 100mg tablets from trusted pharmacy sources. This ensures safety, correct dosage, and genuine quality.

Medical Disclaimer

This content is for educational purposes only. Imatinib Mesylate 100mg must be used only under the supervision of a qualified healthcare professional such as an oncologist or hematologist, depending on the medical condition.